John P. Kirkpatrick - Concepedia

Author

John P. Kirkpatrick

Also Known As

D. A. Reardon, J KIRKPATRICK, J Kirkpatrick, J P Kirkpatrick, J. KIRKPATRICK, J. Kirkpatrick, J. P. Kirkpatrick, J.P Kirkpatrick, J.P. Kirkpatrick, JP Kirkpatrick

412

Publications

13.1K

Citations

H-Index

135

Concepts

All Affiliations

Duke Medical Center Duke University Duke University Hospital Yale University Massachusetts General Hospital

About

John P. Kirkpatrick is an author at Duke Medical Center specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	58	5.4K
2	Health Sciences	22	29	2.8K
3	Engineering	9	9	151
4	Biomedical Engineering	2	2	25
5	Public Health	1	1	33

John P. Kirkpatrick

108

Publications

10K

Citations

H-Index

Page 1

	Year	Citations
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases Paul W. Sperduto, Norbert Kased, David Roberge, Journal of Clinical Oncology	2011	1.4K
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients Paul W. Sperduto, Samuel T. Chao, Penny K. Sneed, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyBrain MetastasesMedicineNeurologyHigh-grade Gliomas	2009	975
Estimating Survival in Patients With Lung Cancer and Brain Metastases Paul W. Sperduto, Jonathan T. Yang, Kathryn Beal, JAMA Oncology	2016	646
The Linear-Quadratic Model Is Inappropriate to Model High Dose per Fraction Effects in Radiosurgery John P. Kirkpatrick, Jeffrey Meyer, Lawrence B. Marks Seminars in Radiation Oncology Adaptive RadiotherapyModel High DoseRadiation MedicineMedical ImagingRadiation Therapy	2008	496
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient Paul W. Sperduto, Shane Mesko, Jing Li, Journal of Clinical Oncology	2020	424
Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases Paul W. Sperduto, Norbert Kased, David Roberge, International Journal of Radiation OncologyBiologyPhysics Prognostic AssessmentNeuro-oncologyTumor SubtypeBreast OncologyPrognostic Evaluation	2011	367
Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity Josef S Smolen, Gabriele Eberl, Ferdinand C. Breedveld, Arthritis & Rheumatism	1995	287
Quantitative analysis of the factors which affect the interpatient organ‐at‐risk dose sparing variation in IMRT plans L. Yuan, Yaorong Ge, W. Robert Lee, Medical Physics	2012	276
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline John P. Kirkpatrick, John B. Fiveash, Helen A. Shih, Practical Radiation Oncology Neuro-oncologyRadiation MedicineOncologyRadiation TherapyAmerican Society	2016	238
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA) Paul W. Sperduto, Wen Jiang, Paul D. Brown, International Journal of Radiation OncologyBiologyPhysics Prognostic EvaluationPrognostic BiomarkersBrain MetastasesMedicineMelanoma	2017	202

Page 1